Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M87.4Revenue $M0.3Net Margin (%)-9,829.0Altman Z-Score9.2
Enterprise Value $M-17.4EPS $-1.0Operating Margin %-9,992.3Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.1Pre-tax Margin (%)-9,791.5Higher ROA y-yY
Price/Book0.910-y EBITDA Growth Rate %--Quick Ratio27.0Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio27.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-20.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-21.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M33.9ROIC % (ttm)-196.1Gross Margin Increase y-yN

Gurus Latest Trades with TRGT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TRGTGeorge Soros 2014-09-30 Sold Out $2.49 - $4.66
($3.11)
$ 2.58-17%Sold Out0
TRGTGeorge Soros 2014-06-30 Buy $3.61 - $4.79
($4.14)
$ 2.58-38%New holding13,800
TRGTFirst Eagle Investment 2012-12-31 Sold Out -0.01%$3.99 - $4.78
($4.43)
$ 2.58-42%Sold Out0
TRGTFirst Eagle Investment 2012-09-30 Reduce-0.01%$4.22 - $5.12
($4.54)
$ 2.58-43%Reduce 58.86%600,000
TRGTSeth Klarman 2012-03-31 Sold Out -1%$5.03 - $7.5
($5.92)
$ 2.58-56%Sold Out0
TRGTFirst Eagle Investment 2012-03-31 Add0.02%$5.03 - $7.5
($5.92)
$ 2.58-56%Add 584.30%1,368,600
TRGTSeth Klarman 2011-12-31 Buy 1%$4.99 - $19.25
($11.54)
$ 2.58-78%New holding6,000,000
TRGTFirst Eagle Investment 2011-12-31 Buy $4.99 - $19.25
($11.54)
$ 2.58-78%New holding200,000
TRGTFirst Eagle Investment 2009-09-30 Sold Out $2.37 - $21.29
($12.04)
$ 2.58-79%Sold Out0
TRGTFirst Eagle Investment 2009-06-30 Add$2.35 - $3.59
($2.93)
$ 2.58-12%Add 93.80%121,302
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TRGT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


TRGT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hodges Mauri KVP, Fin. & Admin., CFO, Treas. 2014-12-11Sell0$0 view
Hodges Mauri KVP, Fin. & Admin., CFO, Treas. 2014-12-11Sell0$0 view
BARRETT M JAMES10% Owner 2013-12-05Sell16,000$5.37-51.96 view
BARRIS PETER J10% Owner 2013-12-05Sell1,000$5.13-49.71 view
SANDELL SCOTT D10% Owner 2013-12-05Sell1,000$5.13-49.71 view
SANDELL SCOTT D10% Owner 2013-11-21Sell5,333$5.16-50 view
BARRIS PETER J10% Owner 2013-11-21Sell5,333$5.16-50 view
BARRETT M JAMES10% Owner 2013-11-21Sell5,333$5.16-50 view
BROWN JULIA RDirector 2013-05-10Buy6,000$5.09-49.31 view
HILL STEPHEN APresident and CEO 2013-03-11Buy20,000$4.43-41.76 view

Quarterly/Annual Reports about TRGT:

News about TRGT:

Articles On GuruFocus.com
Weekly Three-Year Low Highlights: ESIO, VJET, TRGT, ZX May 13 2014 
Why Should You Invest Only in High-Quality Companies? Jun 13 2012 
Seth Klarman Buys 25.5 Million Shares of Global Media Conglomerate Vivendi Apr 17 2012 
Seth Klarman Gives Up Targacept; Sold Out Apr 10 2012 
4 Mar 20 2012 
6 Feb 11 2012 
Seth Klarman Latest Portfolio: Buys IDIX, NG, ANV, Sells PDLI, ALR, BBEP Feb 10 2012 
Seth Klarman Feb 08 2012 
comment on TRGT Dec 28 2011 
comment on TRGT Dec 28 2011 

More From Other Websites
Catalyst Biosciences Announces Positive Results From a Phase 1 Clinical Trial of Its Next Generation... Jun 24 2015
Catalyst Biosciences to Present at the Jefferies 2015 Global Healthcare Conference May 28 2015
TARGACEPT INC Financials May 16 2015
May 14, 2015 Targacept and Catalyst Biosciences Amend Definitive Merger Agreement May 14 2015
TARGACEPT INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or... May 14 2015
Targacept and Catalyst Biosciences Amend Definitive Merger Agreement May 14 2015
TARGACEPT INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... May 12 2015
10-Q for Targacept, Inc. May 09 2015
TARGACEPT INC Files SEC form 10-Q, Quarterly Report May 07 2015
10-K for Targacept, Inc. May 03 2015
3 Stocks Under $10 to Trade for Big Breakouts Apr 23 2015
April 16, 2015 Targacept Announces Negative Top-Line Results from Exploratory Study of TC-6499 in... Apr 19 2015
Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog Apr 17 2015
TARGACEPT INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 16 2015
Targacept Announces Negative Top-Line Results from Exploratory Study of TC-6499 in Diabetic... Apr 16 2015
The Zacks Analyst Blog Highlights: Alkermes, Regulus, Juno Therapeutics, Targacept and Gilead -... Apr 09 2015
Targacept Crumbles as Pfizer Pulls Out of Collaboration - Analyst Blog Apr 07 2015
TARGACEPT INC Files SEC form 8-K, Other Events Apr 06 2015
TARGACEPT INC Files SEC form 8-K, Change in Directors or Principal Officers Mar 17 2015
TARGACEPT INC Files SEC form 10-K, Annual Report Mar 16 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK